Tumor cells can express inhibitory ligands such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death ligand 1 (PD-L1), which send “stop” signals to active T cells, enabling the tumor to escape cell-mediated immunity. Here, CTLA4 is linked to neoplasm.